Bicara Therapeutics

Bicara Therapeutics

A clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. . Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€600—900m (Dealroom.co estimates Dec 2023.)
Cambridge Massachusetts (HQ)
Authorizing premium user...